My watch list  


The antimuscarinic Fesoterodine is a drug developed by Schwarz Pharma AG to treat Overactive bladder syndrome.[1] It was recommended for approval by the European Medicines Agency in February 2007, but is not yet available for use.[citation needed]


  1. ^ Fesoterodine, New Drug Candidate For Treatment For Overactive Bladder - Pfizer To Acquire Exclusive Worldwide Rights. Medical News Today (17 April 2006).

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Fesoterodine". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE